JSA advised Intellihealth Solutions Private Limited (d/b/a Truemeds) and its Founders on their Series C fundraise. The round’s first close was led by Accel, followed by a second close led by Peak XV Partners, with significant participation from existing investors WestBridge and InfoEdge Ventures.

Truemeds is a leading telehealth platform focused on enhancing affordability and accessibility in healthcare, primarily through the provision of generic and substitute medicines.

The JSA transaction team comprised Rishabh Gupta (Partner), Akshath Mithal (Principal Associate), Tanmayee Shriprasad Apte (Associate), and Saurabh Chatterji (Associate).